Abstract
We created a computational modeling platform to predict the effects of fulvestrant/palbocilib treatment on WT-ER and Y537S-mutant breast cancer cells, and found that continuous treatment schedules are more effective than the standard, pulsed-dose palbociclib treatment schedule.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have